Jazz Pharmaceuticals (JAZZ) EBIT Growth (3y) (2013 - 2026)
Jazz Pharmaceuticals (JAZZ) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
16.35% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-50.81% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Jazz Pharmaceuticals |
13.91 Bn |
12.06 Bn |
934.80 Mn |
38.73% |
| Date | Value |
|---|
| Mar 31, 2026 |
38.73% |
| Dec 31, 2025 |
43.68% |
| Sep 30, 2025 |
32.43% |
| Jun 30, 2025 |
-115.61% |
| Mar 31, 2025 |
-38.18% |
| Dec 31, 2024 |
56.91% |
| Sep 30, 2024 |
109.33% |
| Jun 30, 2024 |
69.46% |
| Mar 31, 2024 |
-25.81% |
| Dec 31, 2023 |
-10.94% |
| Sep 30, 2023 |
-4.22% |
| Jun 30, 2023 |
-7.34% |
| Mar 31, 2023 |
38.64% |
| Dec 31, 2022 |
-84.70% |
| Sep 30, 2022 |
-42.91% |
| Jun 30, 2022 |
-25.18% |
| Mar 31, 2022 |
-13.17% |
| Dec 31, 2021 |
-35.62% |
| Sep 30, 2021 |
-46.83% |
| Jun 30, 2021 |
-34.89% |
